Literature DB >> 17909483

Synthesis of novel nitro-substituted triaryl pyrazole derivatives as potential estrogen receptor ligands.

Fotini Naoum1, Konstantinos M Kasiotis, Prokopios Magiatis, Serkos A Haroutounian.   

Abstract

Novel tetrasubstituted pyrazole derivatives bearing a nitro substituent on their A-phenol ring were synthesized and their binding affinity towards the estrogen receptor (ER) subtypes ERalpha and ERbeta was determined. Among compounds tested, the 2-nitrophenol derivative 5c was found to bind satisfactorily to both estrogen receptor subtypes (RBAalpha=5.17 and RBAbeta=3.27). In general, the introduction of a nitro group into the A ring of these compounds was found to benefit their ERbeta binding abilities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909483      PMCID: PMC6149350          DOI: 10.3390/12071259

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  21 in total

1.  Comparative QSAR analysis of estrogen receptor ligands.

Authors:  H Gao; J A Katzenellenbogen; R Garg; C Hansch
Journal:  Chem Rev       Date:  1999-03-10       Impact factor: 60.622

2.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

Authors:  S R Stauffer; C J Coletta; R Tedesco; G Nishiguchi; K Carlson; J Sun; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  J Med Chem       Date:  2000-12-28       Impact factor: 7.446

Review 4.  Role of estrogen receptor beta in estrogen action.

Authors:  K Pettersson; J A Gustafsson
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

5.  Oxidative chemistry of 2-nitro and 4-nitroestradiol: Dichotomous behavior of radical intermediates and novel potential routes for oxyfunctionalization and B-ring fission of steroidal scaffolds.

Authors:  Alessandro Pezzella; Paola Manini; Alessandra Napolitano; Orlando Crescenzi; Vincenzo Barone; Marco d'Ischia
Journal:  Steroids       Date:  2005-03-29       Impact factor: 2.668

6.  Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.

Authors:  Usha Ghosh; Deshanie Ganessunker; Viswajanani J Sattigeri; Kathryn E Carlson; Deborah J Mortensen; Benita S Katzenellenbogen; John A Katzenellenbogen
Journal:  Bioorg Med Chem       Date:  2003-02-20       Impact factor: 3.641

7.  Nitrosation, nitration, and autoxidation of the selective estrogen receptor modulator raloxifene by nitric oxide, peroxynitrite, and reactive nitrogen/oxygen species.

Authors:  Violeta Toader; Xudong Xu; Adrian Nicolescu; Linning Yu; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2003-10       Impact factor: 3.739

Review 8.  Hormone therapy after endometrial cancer.

Authors:  Alfred O Mueck; Harald Seeger
Journal:  Horm Res       Date:  2004-06-01

9.  ERbeta: a novel estrogen receptor offers the potential for new drug development.

Authors:  S Nilsson; G Kuiper; J A Gustafsson
Journal:  Trends Endocrinol Metab       Date:  1998-12       Impact factor: 12.015

10.  Non-steroidal ligands for steroid hormone receptors.

Authors:  X Lin; V Huebner
Journal:  Curr Opin Drug Discov Devel       Date:  2000-07
View more
  6 in total

1.  The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligands.

Authors:  John A Katzenellenbogen
Journal:  J Med Chem       Date:  2011-07-11       Impact factor: 7.446

2.  One Pot Spiropyrazoline Synthesis via Intramolecular Cyclization/Methylation.

Authors:  Sureshbabu Dadiboyena; Ashton T Hamme
Journal:  Tetrahedron Lett       Date:  2011-05-18       Impact factor: 2.415

3.  Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.

Authors:  Zhiping Zeng; Zhe Sun; Mingfeng Huang; Weidong Zhang; Jie Liu; Liqun Chen; Fan Chen; Yuqi Zhou; Jiacheng Lin; Fengyu Huang; Lin Xu; Zixing Zhuang; Shangjie Guo; Gulimiran Alitongbieke; Guobin Xie; Yang Xu; Bingzhen Lin; Xihua Cao; Ying Su; Xiao-Kun Zhang; Hu Zhou
Journal:  Cancer Res       Date:  2015-03-20       Impact factor: 12.701

4.  Thiophene-core estrogen receptor ligands having superagonist activity.

Authors:  Jian Min; Pengcheng Wang; Sathish Srinivasan; Jerome C Nwachukwu; Pu Guo; Minjian Huang; Kathryn E Carlson; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  J Med Chem       Date:  2013-04-15       Impact factor: 7.446

5.  Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase: design, biological evaluation and in silico studies.

Authors:  Ismail M M Othman; Mohamed A M Gad-Elkareem; Abd El-Galil E Amr; Mohamed A Al-Omar; Eman S Nossier; Elsayed A Elsayed
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 6.  Current status of pyrazole and its biological activities.

Authors:  Mohd Javed Naim; Ozair Alam; Farah Nawaz; Md Jahangir Alam; Perwaiz Alam
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.